Veterinary

Dechra Pharmaceuticals to acquire Invetx

BofA Securities, Inc. is acting as exclusive financial advisor to Invetx and Latham and Watkins LLP is acting as legal advisor

Photo of Cynera Rodricks Cynera Rodricks Send an email Monday, 22 July 2024, 15:08Last Updated: Monday, 22 July 2024, 15:08
1 minute read

UK-based provider of veterinary pharmaceuticals Dechra has announced its plans to acquire Invetx, a Boston, MA-based company which specialises in protein-based therapeutics for animal health, for up to $520m (£402.76m).

Tags
Photo of Cynera Rodricks Cynera Rodricks Send an email Monday, 22 July 2024, 15:08Last Updated: Monday, 22 July 2024, 15:08
1 minute read
Back to top button